Name: UMIN ID:
Unique ID issued by UMIN | UMIN000006476 |
---|---|
Receipt number | R000007687 |
Scientific Title | Multicenter phase II study of adding bevacizumab to oral S-1 therapy in advanced colorectal cancer who have failed prior oxaliplatin and irinotecan-based therapies |
Date of disclosure of the study information | 2011/10/06 |
Last modified on | 2016/11/16 08:41:20 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/10/05 10:46:50 | ||
2 | Update | 2014/01/14 10:20:38 | Recruitment status |
|
3 | Update | 2014/10/12 19:26:11 | TEL |
|
4 | Update | 2016/06/22 11:15:22 | Name of primary person or sponsor Organization |
|
5 | Update | 2016/11/16 08:41:20 | Key inclusion criteria |